| AEXAAmerican Exceptionalism Acquisition Corp. A |
n/d |
n/d |
n/d |
| AMFNAmerican Fusion, Inc. |
n/d |
n/d |
n/d |
| AHRAmerican Healthcare REIT, Inc. |
US$ 2,3 bi |
3,1% |
2025 |
| AHIIAmerican Heritage International Inc. |
n/d |
n/d |
2013 |
| AMHAmerican Homes 4 Rent |
n/d |
n/d |
2025 |
| AIIAmerican Integrity Insurance Group, Inc. |
US$ 276,5 mi |
36,0% |
2025 |
| AMLIFAmerican Lithium Corp. |
n/d |
n/d |
2024 |
| ANG-PDAmerican National Group Inc. |
US$ 7,5 bi |
7,1% |
2025 |
| AOUTAmerican Outdoor Brands, Inc. |
US$ 190,5 mi |
-4,8% |
2026 |
| APHPAmerican Picture House Corp |
US$ 853 mil |
-62,7% |
2025 |
| ARECAmerican Resources Corp |
US$ 0 |
n/d |
2025 |
| NYCAmerican Strategic Investment Co. |
n/d |
n/d |
2025 |
| AVACAmerican Ventures Acquisition Corp. I |
n/d |
n/d |
n/d |
| AWKAmerican Water Works Company, Inc. |
US$ 5,1 bi |
21,6% |
2025 |
| AMWLAmerican Well Corp |
US$ 249,3 mi |
-38,4% |
2025 |
| USASAmericas Gold & Silver Corp |
US$ 117,9 mi |
-74,1% |
2025 |
| ABCBAmeris Bancorp |
n/d |
n/d |
2025 |
| AMSTAmesite Inc. |
US$ 364,8 mil |
-848,7% |
2026 |
| AMRXAmneal Pharmaceuticals, Inc. |
US$ 3 bi |
2,4% |
2025 |
| APMCAmperCap Acquisition Co |
n/d |
n/d |
n/d |
| AMPHAmphastar Pharmaceuticals, Inc. |
US$ 719,9 mi |
13,6% |
2025 |
| AMPGAmpliTech Group, Inc. |
US$ 25,2 mi |
-27,8% |
2025 |
| BDRYAmplify Commodity Trust |
n/d |
n/d |
2026 |
| AMPYAmplify Energy Corp. |
US$ 263,4 mi |
16,7% |
2025 |
| AMPLAmplitude, Inc. |
US$ 343,2 mi |
-25,8% |
2025 |
| AMPXAmprius Technologies, Inc. |
US$ 73 mi |
-60,3% |
2025 |
| AMRZAmrize Ltd |
US$ 11,8 bi |
10,0% |
2025 |
| AMLXAmylyx Pharmaceuticals, Inc. |
US$ 0 |
n/d |
2025 |
| NNNNAnbio Biotechnology |
US$ 8,6 mi |
74,1% |
2025 |
| ANDGAndersen Group Inc. |
US$ 838,7 mi |
-0,3% |
2025 |
| ANDEAndersons, Inc. |
US$ 11 bi |
0,9% |
2025 |
| POLEAndretti Acquisition Corp. II |
n/d |
n/d |
2025 |
| ANEBAnebulo Pharmaceuticals, Inc. |
n/d |
n/d |
2025 |
| FINSAngel Oak Financial Strategies Income Term Trust |
n/d |
n/d |
n/d |
| AOMRAngel Oak Mortgage REIT, Inc. |
n/d |
n/d |
2025 |
| ASCIXAngel Oak Strategic Credit Fund |
n/d |
n/d |
n/d |
| ANGXAngel Studios, Inc. |
US$ 321,6 mi |
-53,0% |
2025 |
| ANGHAnghami Inc |
US$ 78,1 mi |
-81,4% |
2024 |
| ANGIAngi Inc. |
US$ 1 bi |
4,3% |
2025 |
| AUAngloGold Ashanti PLC |
US$ 9,9 bi |
32,1% |
2025 |
| BUDAnheuser-Busch InBev SA |
US$ 59,3 bi |
11,5% |
2025 |
| ANIKAnika Therapeutics, Inc. |
US$ 112,8 mi |
-9,6% |
2025 |
| ANIXAnixa Biosciences Inc |
n/d |
n/d |
2025 |
| ANKMAnkam, Inc. |
US$ 325 mil |
-20,7% |
2025 |
| ANNXAnnexon, Inc. |
n/d |
n/d |
2025 |
| ANVSAnnovis Bio, Inc. |
US$ 0 |
n/d |
2025 |
| ANTAAntalpha Platform Holding Co |
US$ 79,7 mi |
30,7% |
2025 |
| AEHLAntelope Enterprise Holdings Ltd |
US$ 98,8 mi |
-10,7% |
2024 |
| AVRAnteris Technologies Global Corp. |
US$ 1,9 mi |
-4.921,3% |
2025 |
| ATEXAnterix Inc. |
US$ 6,5 mi |
1.394,2% |
2026 |